Since we have a new thread due to the new Biotron video, here's some of my previous post (modified) for the sake of newcomers.
Biotron is examining 2019nCoV. GREAT NEWS!
It is completely ridiculous that they would not be pursuing the new virus. Finding a solution to all coronaviruses is a significant part of their portfolio. Pursuing nCoV was a given in my mind.
Moving on. As stated by MM, BIT will gain access to the new cloned virus and commence work. What will be the outcome? No one knows. But BIT will pursue it in line with their specific unique method. For those not clued up, other labs are attempting to develop a vaccine focusing on the S Proteins. These are the large spikes projecting from the virus that you see on 3D images on the evening news. These spikes are primarily responsible for the virus attaching onto host cells, and is what most antivirals work against, such as the HIV antivirals that are being used to combat nCoV so far. In the case of HIV, the standard antivirals are capable of killing HIV only in certain areas of the human body, mostly within blood vessels, but not in organs. This is why HIV is not cured, as the virus still remains in certain human organs where antivirals don't penetrate, and this is why patients require to continually take the antivirals for their lifetime.
But BIT has managed to remove the hidden HIV and eradicate the virus by discovering a method that interrupts the Ion Channel of the much smaller E Protein that is responsible for essential stages of the virus life cycle. This Ion Channel of the E Protein is like a pathway between the virus and host cell, and even though not unique to the E Protein, it is here that when interrupted, the virus dies.This is how BIT has managed to eradicate hidden HIV cells that other HIV antivirals cannot. Phase 3 trials will commence in due course.
But back to the nCoV2019. BIT will pursue the same approach utilizing the E Protein. This is where they have had enormous success in eradicating hidden HIV and the same method is being applied to other viruses including numerous types of humancorona that they have so far worked with.
Moving forward with the nCoV cloned material in hand, there are two aspects for development.
Firstly, BIT's forthcoming work with nCoV as they see fit. It will follow the same methodology as their recent work with other strains of humancorona virus.
Secondly. Standard HIV antivirals are being used as a first treatment for the new coronavirus. For those unfamiliar, HIV antivirals have been used with some success on the previous forms of coronavirues, specifically SARS and MERS. It may be the case that any limitations are are caused by the same limitations that standard HIV antivirals experience when treating HIV. If so, then maybe adding BIT225 into the mix as Biotron have suggested with HIV, will have the same positive effect with 2019nCov.
I believe BIT225 should be used immediately with other HIV antivirals as the first response treatment for 2019nCoV, and if the Chinese were aware, I'm sure they would agree.
There is absolutely nothing to lose and maybe much to gain.
Back to work for me.
If not too late, I should add that we will hear from BIT on these matters very soon.
Expand
